First Databank (FDB), the leading provider of clinical drug knowledge that improves medication-related decisions and patient outcomes, today announced that FDB AlertSpace, a web-based solution for drug knowledge alert management in CPOE systems, will be made available to Siemens Soarian Clinicals customers and Siemens Pharmacy in-house computing option (ICO) users.
Customizing drug knowledge in electronic health record systems is often performed in an effort to address the widespread industry problem of alert fatigue in health IT systems. Since its introduction in early 2012, hundreds of hospitals as well as numerous long term care facilities have licensed AlertSpace. The solution enables Siemens users to customize medication dosing, drug-drug interactions and duplicate therapy drug alerts and provides a “starter set” of high priority and low priority drug-drug interactions recommended by the Office of the National Coordinator for Health IT (ONC).
Unique “crowd sourcing” tools also available within AlertSpace allow users to view aggregated, anonymized data on alert customizations made by all AlertSpace users, providing a starting point for focusing customization efforts. Users are also actively communicating and collaborating online about customizations within their organization via AlertSpace.
“We are extremely excited to offer AlertSpace to our Siemens customers who share many of the industry-wide challenges in managing alert fatigue in their institutions,” said Virginia Halsey, product management director-AlertSpace, FDB. “In just a few short years, we are gratified by the widespread industry acceptance this unique solution has achieved, demonstrating that alert fatigue can be managed when clinicians are given easy-to-use customization tools that work seamlessly with their health IT systems.”
FDB drug knowledge experts will be demonstrating AlertSpace and all FDB drug knowledge solutions at the HIMSS14 Conference, February 23 – 27, Orlando, Florida in booth number 1965.
About First Databank (FDB)
First Databank (FDB) provides drug knowledge that helps healthcare professionals make precise medication-related decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver a wide range of valuable, useful, and differentiated solutions. As the company that virtually launched the medication decision support category, we offer more than three decades of experience in transforming drug knowledge into actionable, targeted, and effective solutions that improve patient safety and healthcare outcomes. For a complete look at our solutions and services please visit www.fdbhealth.com and follow us on Twitter and LinkedIn.
About Hearst Health
FDB is part of the Hearst Health network, which also includes Zynx Health, MCG (formerly Milliman Care Guidelines) and Homecare Homebase. The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from the Hearst Health network reaches 76% of discharged patients, 133 million insured individuals, 20 million home health visits, 1.88 billion retail pharmacy prescriptions and 3.26 billion prescription claims. Extensions of the Hearst Health network include Hearst Health Ventures and the Hearst Health Innovation Lab.